Skip to main content
Menu
US

HTRF Human STING Binding Kit, 10,000 Assay Points

The human STING WT binding assay is designed to select and characterize compounds that specifically bind human STING protein.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein-Protein Interaction
Sample Volume 5 µL

The human STING WT binding assay is designed to select and characterize compounds that specifically bind human STING protein.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
64BDSTGPEG
List Price
USD 2,091.00
Unit Size: 10,000 Assay Points
Part #:
64BDSTGPEH
List Price
USD 24,550.00

Overview

A fast and easy way to identify new binders to human STING WT (R232).

Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173), is a protein playing a major role in innate immunity. Upon intracellular cytosolic DNA release from pathogens such as viruses and bacteria, 2’-3’cGAMP binds to STING protein and triggers the secretion of type 1 interferon. Identifying new STING ligands is therefore a way to control immunity and fight autoinflammatory diseases.

Specifications

Application
Protein-Protein Interaction
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Binding Assay
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Infectious Diseases
Oncology & Inflammation
Unit Size
10,000 Assay Points

Video gallery

How it works

Assay principle

The HTRF STING binding assay is a competitive assay format which uses d2-labeled STING ligand, a 6His tagged human STING protein, and an anti 6His Cryptate-labeled antibody. Your compound competes with the STING ligand-d2 and thereby prevents FRET from occurring.

htrf-sting-human-binding-assay-1.svg
Assay protocol

The Human STING binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, samples or standards are dispensed directly into the assay plate, the human His-tagged STING protein is then added followed by the dispensing of the HTRF reagents: the anti 6His antibody labeled with Terbium cryptate and  the STING ligand labeled with d2. The reagents labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

htrf-sting-human-binding-assay-2.svg

 

Assay details

STING ligand-d2 - Kd 15 nM
STING ligand-d2 - Concentration 15 nM
2’3’ cGAMP Standard - IC50 5 nM
2’3’ cGAMP Standard - Ki 2.5 nM
Signal to Background 12.4

 

Assay validation

Compound screening

Various compounds known as STING ligands were added to the assay. 2’-3’ cGAMP (assay standard), cyclic di-AMP, and cyclic di-GMP display the right potency in good correlation with the literature. DMXAA, a non-specific compound, also well-known mouse STING binder, has no effect on the assay, confirming the human specificity of the kit.

htrf-sting-human-binding-assay-3.svg

 

Simplified pathway

STING simplified pathway

STING, for STimulator of INterferon Genes, is a cytoplasmic homodimeric protein localized in the endoplasmic reticulum which plays an essential role in innate immunity. Upon pathogen infection or mitochrondrial shrinking during apoptosis, floating dsDNAs bind and activate a DNA sensor, the cyclic GMP-AMP synthase (cGAS). Activated cGAS leads to the production of 2’-3’cGAMP, a cyclic dinucleotide, which then binds to STING proteins. In turn, phosphorylated STING interacts with TANK-binding-kinase-I (TBK1), leading to the recruitment and activation of the active interferon regulatory factor (IRF3) dimer. Nuclear translocation of the IRF3 dimer leads to the transcription of genes encoding IFN-α/β. In addition, the STING pathway controls NF-κB dependent inflammatory cytokine expression. As a negative feedback loop, the DNA-stimulated cGAS-STING-TBK1 pathway also triggers STING protein degradation through p62 SQSTM1 associated autophagy to switch off IFNb production.

htrf-sting-human-binding-assay-4.svg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon